◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
之江生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 179.0M 274.0M 2.3B 2.0B 2.1B
Revenue Growth % -34.7% -88.2% 15.2% -1.6% --
Total Revenue 179.0M 274.0M 2.3B 2.0B 2.1B
Cost Of Revenue 69.8M 95.7M 1.1B 757.0M 535.0M
+Gross Profit 109.2M 178.3M 1.2B 1.3B 1.5B
Gross Margin % 61.0% 65.1% 51.6% 62.5% 73.9%
Total Operating Cost 334.0M 452.0M 1.5B 1.1B 948.0M
Selling Expenses 55.6M 95.2M 258.0M 211.0M 280.0M
Admin Expenses 95.6M 89.5M 83.3M 50.8M 40.7M
Rd Expenses 58.8M 61.0M 105.0M 109.0M 52.4M
Finance Expenses -127.0M -84.8M -108.0M -2.4M 26.2M
+Operating Income -146.0M -149.0M 907.0M 901.0M 1.1B
Operating Margin % -81.6% -54.4% 39.0% 44.6% 54.2%
Non Operating Income 2.1M 1.1M 600.00 17,300 898,400
Non Operating Expenses 7.0M 8.2M 5.9M 4.8M 3.4M
Investment Income 57,100 -- -- -- --
Fair Value Change Income -- -- -- -- --
Asset Disposal Income 39,300 -- 30,900 -- --
Asset Impairment Loss 163.0M 186.0M 4.6M 5.0M 710,400
Other Income 9.4M 27.8M 62.6M 31.7M 7.4M
Income Before Tax -151.0M -157.0M 901.0M 896.0M 1.1B
Income Tax -23.1M -19.8M 141.0M 138.0M 177.0M
+Net Income -127.0M -137.0M 760.0M 759.0M 932.0M
Net Margin % -70.9% -50.0% 32.7% 37.6% 45.4%
Net Income Attributable -127.0M -137.0M 760.0M 759.0M 932.0M
Minority Interest -- -- -- -- --
Eps Basic -0.67 -0.71 3.93 3.98 6.38
Eps Diluted -0.67 -0.71 3.93 3.98 6.38
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 2.8B 2.8B 3.1B 2.9B 1.2B
Trading Financial Assets -- -- -- -- --
Accounts Receivable 55.0M 102.0M 228.0M 215.0M 230.0M
Notes Receivable 247,000 -- 7,200 2.9M 380,200
Notes And Accounts Receivable 55.3M 102.0M 228.0M 218.0M 230.0M
Prepayments 11.8M 12.6M 20.2M 17.7M 11.9M
Inventory 57.4M 254.0M 504.0M 299.0M 132.0M
Total Current Assets 2.9B 3.2B 3.9B 3.6B 1.6B
Long Term Equity Investment -- -- -- -- --
Fixed Assets -- 734.0M 652.0M 561.0M 123.0M
Fixed Assets Total 676.0M 734.0M 652.0M 561.0M 123.0M
Construction In Progress -- 2.1M 1.2M 984,600 1.8M
Construction In Progress Total 343,000 2.1M 1.2M 984,600 1.8M
Intangible Assets 7.8M 6.1M 6.8M 6.6M 3.7M
Long Term Deferred Expenses 3.8M 2.9M 3.7M -- --
Total Non Current Assets 854.0M 908.0M 834.0M 702.0M 297.0M
Total Assets 3.8B 4.1B 4.7B 4.3B 1.9B
Short Term Borrowings -- -- -- -- --
Accounts Payable 78.8M 121.0M 318.0M 237.0M 160.0M
Advance Receipts -- -- -- -- --
Contract Liabilities 15.3M 24.0M 59.3M 55.3M 50.5M
Total Current Liabilities 146.0M 237.0M 524.0M 409.0M 385.0M
Long Term Borrowings -- -- -- -- --
Total Non Current Liabilities 7.1M 12.7M 19.6M 18.3M 31.6M
Total Liabilities 153.0M 249.0M 543.0M 427.0M 417.0M
Paid In Capital 192.0M 195.0M 195.0M 195.0M 146.0M
Capital Reserve 2.1B 2.1B 2.1B 2.1B 257.0M
Surplus Reserve 97.4M 97.4M 97.4M 97.4M 73.0M
Retained Earnings 1.3B 1.5B 1.9B 1.4B 908.0M
Minority Equity -- -- -- -- --
Equity Attributable 3.6B 3.8B 4.2B 3.8B 1.5B
Total Equity 3.6B 3.8B 4.2B 3.8B 1.5B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 215.0M 363.0M 2.4B 2.1B 2.1B
Tax Refunds Received 3.4M 591,100 23.1M 4.4M 843,900
Total Operating Cash Inflow 339.0M 463.0M 2.5B 2.1B 2.1B
Cash Paid For Goods 44.7M 229.0M 1.4B 928.0M 566.0M
Cash Paid To Employees 97.6M 122.0M 152.0M 126.0M 71.0M
Taxes Paid 20.6M 53.6M 212.0M 266.0M 181.0M
Total Operating Cash Outflow 261.0M 544.0M 2.0B 1.5B 960.0M
Operating Cash Flow 77.6M -81.9M 585.0M 642.0M 1.1B
Total Investing Cash Inflow 21.6M 3.5M 49.7M -- 274,700
Total Investing Cash Outflow 41.0M 81.1M 126.0M 519.0M 86.6M
Investing Cash Flow -19.4M -77.7M -76.0M -519.0M -86.3M
Cash From Borrowings -- -- -- -- --
Dividends And Interest Paid 20.9M 231.0M 266.0M 312.0M 65.7M
Debt Repayments -- -- -- -- --
Total Financing Cash Inflow -- -- -- 2.0B --
Total Financing Cash Outflow 58.7M 234.0M 371.0M 331.0M 68.5M
Financing Cash Flow -58.7M -234.0M -371.0M 1.6B -68.5M
Net Change In Cash 13.9M -378.0M 212.0M 1.7B 959.0M
Ending Cash Balance 2.8B 2.8B 3.1B 2.9B 1.2B
Capex 19.5M 81.1M 74.6M 498.0M 74.6M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...